Brief: Respiratorius: EMA recommends European Orphan Drug Designation for VAL001

Respiratorius AB (publ)

07/10/2016 12:38

Oct 7 (Reuters) - Respiratorius AB (publ)  RESPS.ST : 
    * The European Medicines Agency's Committee for Orphan Drugs in Europe (the Committee for 
Orphan Medicinal Products - COMP) has informed Respiratorius of a positive decision regarding 
Respiratorius application for VAL001 to obtain Orphan Drug Designation in Europe 
 
     
 Source text: http://bit.ly/2dxwT5M 
     
 Further company coverage:  RESPS.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))